Review



mouse  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Miltenyi Biotec mouse
    Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 94 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/CD8+(TIL)+MicroBeads%2C+mouse/pmc13084401-31-3-5
    Average 96 stars, based on 94 article reviews
    mouse - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Isolation:

    Article Title: PD-1 regulates latent effector differentiation of thymic cytotoxic CD8 + T cells.
    Article Snippet: Dead cells were further removed using Dead cell Removal kit (Miltenyi Biotec, Cat# 130-090-101). .. CD8+ TILs were then isolated using CD8 (TIL) microbeads, mouse (Miltenyi Biotec, Cat#130-116-478). ..

    Article Title: Shengxian decoction suppresses malignant progression of lung adenocarcinoma by enhancing CD8 + T cell function via the FYN-PI3K/AKT axis.
    Article Snippet: .. CD8+ T cells were isolated from fresh mouse spleens using magnetic bead sorting (130-116-478, Miltenyi Biotec, China). ..

    Article Title: Protocol for immunomagnetic enrichment of CD8 T cells from complex murine tissues.
    Article Snippet: .. Timing: 35 min per sample Here, we describe the enrichment of CD8 T cells from single cell suspensions of liver, heart, kidney and BM cells using the Miltenyi Biotec CD8 (TIL) MicroBeads (Figure 5), which were developed for the isolation of CD8 T cells from mouse tumors. ..

    Article Title: High-Fat Diet Remodels Plasma Membrane Rigidity to Potentiate Colonocyte Stemness in Mice
    Article Snippet: .. Mouse spleens were collected, and CD4 + and CD8 + T cells were isolated by positive selection using magnetic CD4 (L3T4) (Miltenyi Biotec, 130-049-201) or CD8 (TIL) (Miltenyi Biotec, 130-116-478) microbeads according to the manufacturer’s protocol. ..

    Article Title: Therapeutic RNA for HPV-positive cancer
    Article Snippet: Tumor and lymph node single cell suspensions, as well as whole spleens, were forced through a 70 μm cell strainer (BD Falcon), using the plunger end of a syringe, while rinsing with PBS. .. Cells were centrifuged at 460 g for 6 min and erythrocytes lysed with a hypotonic electrolyte solution for 5 min. For the isolation CD8 TIL, target cells were magnetically enriched using the mouse CD8 (TIL) MicroBeads (Miltenyi Biotech) according to manufacturer's instructions. ..

    Single Cell:

    Article Title: Protocol for immunomagnetic enrichment of CD8 T cells from complex murine tissues.
    Article Snippet: .. Timing: 35 min per sample Here, we describe the enrichment of CD8 T cells from single cell suspensions of liver, heart, kidney and BM cells using the Miltenyi Biotec CD8 (TIL) MicroBeads (Figure 5), which were developed for the isolation of CD8 T cells from mouse tumors. ..

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth

    Selection:

    Article Title: High-Fat Diet Remodels Plasma Membrane Rigidity to Potentiate Colonocyte Stemness in Mice
    Article Snippet: .. Mouse spleens were collected, and CD4 + and CD8 + T cells were isolated by positive selection using magnetic CD4 (L3T4) (Miltenyi Biotec, 130-049-201) or CD8 (TIL) (Miltenyi Biotec, 130-116-478) microbeads according to the manufacturer’s protocol. ..

    Purification:

    Article Title: IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.
    Article Snippet: 7 days after the surgery, an initial bioluminescence measurement was performed (IVIS Luminalll, Perkin Elmer) 15 min after i.p injection of luciferin (150 mg/ kg). .. For the purification of intratumor NK or CD8 T cells, the mouse NK Cell Isolation kit followed by the mouse CD45 (TIL) Microbeads kit (130–115- 818 and 130–110- 618, Miltenyi Biotec) or the CD8 (TIL) Microbeads kit (130–116- 478, Miltenyi Biotec) were used respectively. .. For splenic immune cell isolation, spleen and lymph nodes from naïve mice were harvested and then dissociated before being filtered on a 70 μm filter (130–110- 916, Miltenyi Biotec).

    Cell Isolation:

    Article Title: IL-10 secretion by CD8 T cells orchestrates early NK cell recruitment and antitumor immunity after anti-VEGFR-2/PD-1 therapy.
    Article Snippet: 7 days after the surgery, an initial bioluminescence measurement was performed (IVIS Luminalll, Perkin Elmer) 15 min after i.p injection of luciferin (150 mg/ kg). .. For the purification of intratumor NK or CD8 T cells, the mouse NK Cell Isolation kit followed by the mouse CD45 (TIL) Microbeads kit (130–115- 818 and 130–110- 618, Miltenyi Biotec) or the CD8 (TIL) Microbeads kit (130–116- 478, Miltenyi Biotec) were used respectively. .. For splenic immune cell isolation, spleen and lymph nodes from naïve mice were harvested and then dissociated before being filtered on a 70 μm filter (130–110- 916, Miltenyi Biotec).

    Recombinant:

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth

    Chromatin Immunoprecipitation:

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth

    Enzyme-linked Immunosorbent Assay:

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth

    Software:

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth

    Ointment:

    Article Title: Respiratory viral infections prime accelerated lung cancer growth.
    Article Snippet: Short article Respiratory viral infections prime accelerated lung cancer growth



    Similar Products

    94
    Vazyme Biotech Co mouse cd8 t cell isolation kit
    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated <t>CD8</t> + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.
    Mouse Cd8 T Cell Isolation Kit, supplied by Vazyme Biotech Co, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/Mouse+CD8%2B+T+Cell+Isolation+Kit/pmc13752232-360-11-19
    Average 94 stars, based on 1 article reviews
    mouse cd8 t cell isolation kit - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    99
    MedChemExpress cd8 t cells
    BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following <t>Bafilomycin</t> <t>A1</t> <t>(BafA1)</t> treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.
    Cd8 T Cells, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/Bafilomycin+A1/pmc13755765-270-13-26
    Average 99 stars, based on 1 article reviews
    cd8 t cells - by Bioz Stars, 2026-11
    99/100 stars
      Buy from Supplier

    97
    Bio X Cell anti mouse cd8 antibody
    Single‐cell transcriptomic profiling of the cellular landscape in endometriosis. (A) Schematic representation of the experimental strategy. (B) UMAP visualization of 83,572 cells from 11 samples. (C) UMAP plots split by PF (top) and tissue (bottom) groups. (D) Dot plot showing canonical marker genes used to annotate each cell type. Dot size reflects the fraction of expressing cells, and color depth reflects mean expression. (E) Cell‐type composition of PF samples across individuals. (F) Flow cytometric validation of macrophage proportions in PF (left; Endo, n = 18; Ctrl, n = 10) and <t>CD8</t> + T cell (middle) and NK cell (right) proportions in tissues (Endo, n = 25; Ctrl, n = 14). (G) Alluvial plot of intercellular signaling patterns. Cell types are connected to communication patterns and their corresponding signaling pathways. Ribbon width is proportional to the relative contribution of each cell type to a given pattern. (H) Cell–cell communication network. Node size reflects total interaction count, and edge width reflects the number of ligand–receptor pairs. (I) Chord diagram of pairwise ligand–receptor interactions. Line color denotes the sender cell type, and line width indicates interaction strength. (J) Outgoing versus incoming interaction strength for each cell type. Macrophages ranked highest on both axes. (K) KEGG enrichment of macrophage‐associated genes, ordered by gene count. Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (F): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, ** p < 0.01.
    Anti Mouse Cd8 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/InVivoMAb+anti-mouse+CD8%CE%B1/pmc13755765-237-13-17
    Average 97 stars, based on 1 article reviews
    anti mouse cd8 antibody - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    96
    Bio X Cell cd8 t cell depleting antibody
    Single‐cell transcriptomic profiling of the cellular landscape in endometriosis. (A) Schematic representation of the experimental strategy. (B) UMAP visualization of 83,572 cells from 11 samples. (C) UMAP plots split by PF (top) and tissue (bottom) groups. (D) Dot plot showing canonical marker genes used to annotate each cell type. Dot size reflects the fraction of expressing cells, and color depth reflects mean expression. (E) Cell‐type composition of PF samples across individuals. (F) Flow cytometric validation of macrophage proportions in PF (left; Endo, n = 18; Ctrl, n = 10) and <t>CD8</t> + T cell (middle) and NK cell (right) proportions in tissues (Endo, n = 25; Ctrl, n = 14). (G) Alluvial plot of intercellular signaling patterns. Cell types are connected to communication patterns and their corresponding signaling pathways. Ribbon width is proportional to the relative contribution of each cell type to a given pattern. (H) Cell–cell communication network. Node size reflects total interaction count, and edge width reflects the number of ligand–receptor pairs. (I) Chord diagram of pairwise ligand–receptor interactions. Line color denotes the sender cell type, and line width indicates interaction strength. (J) Outgoing versus incoming interaction strength for each cell type. Macrophages ranked highest on both axes. (K) KEGG enrichment of macrophage‐associated genes, ordered by gene count. Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (F): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, ** p < 0.01.
    Cd8 T Cell Depleting Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/InVivoMAb+anti-mouse+CD8%CE%B2/pm42962666-766-14-20
    Average 96 stars, based on 1 article reviews
    cd8 t cell depleting antibody - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Bio X Cell anti cd8 53 5 8 517
    Single‐cell transcriptomic profiling of the cellular landscape in endometriosis. (A) Schematic representation of the experimental strategy. (B) UMAP visualization of 83,572 cells from 11 samples. (C) UMAP plots split by PF (top) and tissue (bottom) groups. (D) Dot plot showing canonical marker genes used to annotate each cell type. Dot size reflects the fraction of expressing cells, and color depth reflects mean expression. (E) Cell‐type composition of PF samples across individuals. (F) Flow cytometric validation of macrophage proportions in PF (left; Endo, n = 18; Ctrl, n = 10) and <t>CD8</t> + T cell (middle) and NK cell (right) proportions in tissues (Endo, n = 25; Ctrl, n = 14). (G) Alluvial plot of intercellular signaling patterns. Cell types are connected to communication patterns and their corresponding signaling pathways. Ribbon width is proportional to the relative contribution of each cell type to a given pattern. (H) Cell–cell communication network. Node size reflects total interaction count, and edge width reflects the number of ligand–receptor pairs. (I) Chord diagram of pairwise ligand–receptor interactions. Line color denotes the sender cell type, and line width indicates interaction strength. (J) Outgoing versus incoming interaction strength for each cell type. Macrophages ranked highest on both axes. (K) KEGG enrichment of macrophage‐associated genes, ordered by gene count. Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (F): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, ** p < 0.01.
    Anti Cd8 53 5 8 517, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/InVivoMAb+anti-mouse+CD8%CE%B2/pm42995492-246-10-16
    Average 96 stars, based on 1 article reviews
    anti cd8 53 5 8 517 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    97
    Miltenyi Biotec mouse cd8 t cell isolation kit
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Mouse Cd8 T Cell Isolation Kit, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/bio_rxiv__64898__2026__11__02__763646-492-11-17
    Average 97 stars, based on 1 article reviews
    mouse cd8 t cell isolation kit - by Bioz Stars, 2026-11
    97/100 stars
      Buy from Supplier

    94
    Bio X Cell mouse invivomab anti mouse cd8 antibody
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Mouse Invivomab Anti Mouse Cd8 Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/InVivoMAb+anti-mouse+CD8/pm42976205-101-30-37
    Average 94 stars, based on 1 article reviews
    mouse invivomab anti mouse cd8 antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Miltenyi Biotec cd8 t cell isolation kits
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Cd8 T Cell Isolation Kits, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/Naive+CD8a%2B+T+Cell+Isolation+Kit%2C+mouse/bio_rxiv__64898__2026__10__31__763323-95-9-19
    Average 96 stars, based on 1 article reviews
    cd8 t cell isolation kits - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    R&D Systems cd8 media
    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, <t>CD8+</t> and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).
    Cd8 Media, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/Recombinant+Human+IL-2+Protein/10__1172_slash_jci207260-214-21-30
    Average 96 stars, based on 1 article reviews
    cd8 media - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Cell Signaling Technology Inc antibody cd8
    (A) Murine constructs binding PD-1 only (Mu-mono-PD-1) or AXL and PD-1 (Mu-BiTE-AXL/PD-1). (B) Binding of mono-AXL and Mu-BiTEto 4NQO-T sgCT (control) and sgAXL cells by flow cytometry. Log scale (FL1), MFI at right; representative of two biological experiments; mean ± SEM of biological duplicates (n=2). Statistical significance was determined using one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (C) Binding of Mu-mono-PD-1 and Mu-BiTE to wild-type (WT) splenocytes, unstimulated versus Concanavalin A (ConA, 1 µg/mL)-stimulated by flow cytometry. Log scale (FL1), MFI at right; single experiment. (D) Schematic of antigen-specific cytotoxicity assay. (E,F) Killing of gp100-pulsed 4NQO-T (n=5) (E) and mEERL (n=4) (F) (target, T), by gp100-reactive <t>CD8+</t> T cells; antibodies at 5 µg/mL, 1:4 T:E ratio; caspase-3/7 by flow cytometry at 16h. Mean ± SEM. Statistical significance was determined using a one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (G) Tumor volume in 4NQO-T CDX subcutaneous model. Randomized mice received i.p. injections twice weekly: Mu-BiTE at various concentrations (0.1, 1, 5 mg/kg) or vehicle (PBS). (n = 6-10 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test compared to vehicle only (only significant P values shown). (H, I) Tumor volume in 4NQO-T CDX (H) and mEERL CDX (I) orthotopic lip models. Randomized mice received i.p. injections twice weekly: mono-Abs combination (mono-AXL+Mu-mono-PD-1, 5 mg/kg each), Mu-BiTE (7.6 mg/kg molar equivalent or 5 mg/kg), or vehicle (PBS). (n = 5-7 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test (adjusted P values shown).
    Antibody Cd8, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd8/CD8alpha+Rabbit+mAb/bio_rxiv__64898__2026__10__26__761755-148-13-15
    Average 96 stars, based on 1 article reviews
    antibody cd8 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    Image Search Results


    Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated CD8 + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: Preparation and characterization of NAD + particles to maintain NAD + levels in MSCs under inflammatory conditions. (A) MSCs viability with or without IT at the indicated time points was measured using the CCK‐8 assay, with statistical analyses presented in relative units ( R.U .) ( n = 3). (B) MSCs‐mediated suppression of anti‐CD3/CD28‐stimulated CD8 + T cell activation. “1d or 5d IT‐treated MSCs” indicates that MSCs were treated with IT for 1 day and 5 days, respectively. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (C) Intracellular NAD(H) levels in MSCs treated with IT for 24 h, along with daily NAD(H) measurements after IT stimulation ( n = 3). (D) mRNA expression of Nampt in MSCs following IT stimulation for 24 h, as measured by qRT‐PCR ( n = 3). (E) Schematic illustration of the interaction between NAD + and PGB. (F) Powder XRD profiles of Ca‐NAD + , NAD + ‐PGB, Ca‐NAD + ‐PGB, and calcium phosphate (CaP). (G) Size and morphology of NANP characterized by dynamic light scattering and transmission electron microscopy. (H) The morphology characterization, HAADF image, and elemental mapping of Ca‐NAD + ‐PGB nanoparticle. (I) The NAD(H) release profiles from NANP under different pH values. (J) Confocal imaging showing the co‐localization of NANP (red, labeled with DiD), lysosomes (green, stained by LysoTracker), and nuclei (blue, stained with Hoechst). Representative quantification of the mean fluorescence intensity (MFI) of NANP and LysoTracker is shown. (K) Intracellular NAD(H) levels of MSCs incubated with 25 µM free NAD + or 25 µM NANP for 2 h ( n = 3). (L) Intracellular NAD(H) levels of MSCs induced by IT with or without 25 µM NANP for 24 h ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: CCK-8 Assay, Activation Assay, Expressing, Quantitative RT-PCR, Morphology, Dynamic Light Scattering Assay, Transmission Assay, Electron Microscopy, Elemental Analysis, Confocal, Imaging, Labeling, Staining, Fluorescence, Incubation

    NAD + supplementation protects MSCs from death and boosts their anti‐inflammatory potential in vivo. (A) The reduction in cell viability of MSCs after IT treatment can be reversed by the addition of 25 µM NANP ( n = 3). (B) TMRE staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, presented as cytofluorometric dot plots and statistical analysis ( n = 3). (C) Annexin V/DAPI dual staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, shown as cytofluorometric dot plots and statistical analysis ( n = 3). (D) MSCs treated with 25 µM NANP, IT, or their combination for 48 h, the expression of apoptosis executors (CASP3 and cleaved CASP3), and necroptosis executors (RIPK3 and p‐RIPK3) was measured by semiquantitative WB. (E) 25 µM NANP restores the ability of 5‐days IT‐treated MSCs to inhibit anti‐CD3/CD28‐stimulated CD8 + T cell proliferation. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (F) Schematic diagram showing the preparation of NAD + ‐loaded MSCs. (G) Schematic diagram showing the MSCs‐treated IBD model. (H) Body weight measurements of IBD mice were administered either MSCs or NAD + ‐loaded MSCs ( n = 5). (I) Colon length of IBD mice and quantitative analysis compared between DSS, MSCs, and NAD + ‐loaded MSCs ( n = 5). (J) Representative H&E‐stained colon sections and histological scores of IBD mice administered by MSCs or NAD + ‐loaded MSCs ( n = 5). (K) IVIS imaging of colon tissues. The mice were euthanized at 48 h after administration, and the colon was immediately removed for imaging with an IVIS Lumina Series (left panel). Average radiant efficiency was compared between MSCs and NAD + ‐loaded MSCs (right panel) ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NAD + supplementation protects MSCs from death and boosts their anti‐inflammatory potential in vivo. (A) The reduction in cell viability of MSCs after IT treatment can be reversed by the addition of 25 µM NANP ( n = 3). (B) TMRE staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, presented as cytofluorometric dot plots and statistical analysis ( n = 3). (C) Annexin V/DAPI dual staining of MSCs treated with 25 µM NANP, IT, or their combination for 48 h, shown as cytofluorometric dot plots and statistical analysis ( n = 3). (D) MSCs treated with 25 µM NANP, IT, or their combination for 48 h, the expression of apoptosis executors (CASP3 and cleaved CASP3), and necroptosis executors (RIPK3 and p‐RIPK3) was measured by semiquantitative WB. (E) 25 µM NANP restores the ability of 5‐days IT‐treated MSCs to inhibit anti‐CD3/CD28‐stimulated CD8 + T cell proliferation. Representative flow cytometric dot plots and statistical analyses are shown ( n = 3). (F) Schematic diagram showing the preparation of NAD + ‐loaded MSCs. (G) Schematic diagram showing the MSCs‐treated IBD model. (H) Body weight measurements of IBD mice were administered either MSCs or NAD + ‐loaded MSCs ( n = 5). (I) Colon length of IBD mice and quantitative analysis compared between DSS, MSCs, and NAD + ‐loaded MSCs ( n = 5). (J) Representative H&E‐stained colon sections and histological scores of IBD mice administered by MSCs or NAD + ‐loaded MSCs ( n = 5). (K) IVIS imaging of colon tissues. The mice were euthanized at 48 h after administration, and the colon was immediately removed for imaging with an IVIS Lumina Series (left panel). Average radiant efficiency was compared between MSCs and NAD + ‐loaded MSCs (right panel) ( n = 3). All data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: In Vivo, Staining, Analysis, Expressing, Imaging

    NANP‐primed MSCs reprogram colitic immunity by restraining inflammatory trafficking. (A) Proportion of CD45 + immune cells in the colon tissues of IBD mice, 6 days post‐MSCs therapy ( n = 6). (B) Distribution of major colonic immune cell subsets, quantified by flow cytometry ( n = 6). (C) Gating strategy for identifying F4/80 + CD206 + macrophages, and statistical analyses are shown ( n = 6). (D) Immunofluorescence imaging of colon sections depicting F4/80 + CD206 + cells (green: F4/80, red: CD206, and blue: DAPI) in MSCs‐treated IBD mice, and statistical analyses were shown ( n = 6). (E, F) RNA sequencing analysis identified differential gene expression in MSCs treated with PBS versus NANP, presented as a volcano plot (E) and Gene Ontology enrichment analysis (F) of significantly regulated genes. (G) Heatmap displaying the differential expression of genes involved in regulating cell migration, comparing PBS and NANP treatment. (H) Heatmap view of differential expression gene involved in negative regulation of apoptosis between MSCs and NANP‐treated MSCs. (I) The combination of 25 µM NANP with IT did not enhance anti‐inflammatory cytokine expression compared to IT alone in MSCs ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Journal: Exploration

    Article Title: Metabolic Nanomedicine Reprograms Mesenchymal Stem Cells for Durable Exosome‐Mediated Immunomodulation

    doi: 10.1002/exp2.70249

    Figure Lengend Snippet: NANP‐primed MSCs reprogram colitic immunity by restraining inflammatory trafficking. (A) Proportion of CD45 + immune cells in the colon tissues of IBD mice, 6 days post‐MSCs therapy ( n = 6). (B) Distribution of major colonic immune cell subsets, quantified by flow cytometry ( n = 6). (C) Gating strategy for identifying F4/80 + CD206 + macrophages, and statistical analyses are shown ( n = 6). (D) Immunofluorescence imaging of colon sections depicting F4/80 + CD206 + cells (green: F4/80, red: CD206, and blue: DAPI) in MSCs‐treated IBD mice, and statistical analyses were shown ( n = 6). (E, F) RNA sequencing analysis identified differential gene expression in MSCs treated with PBS versus NANP, presented as a volcano plot (E) and Gene Ontology enrichment analysis (F) of significantly regulated genes. (G) Heatmap displaying the differential expression of genes involved in regulating cell migration, comparing PBS and NANP treatment. (H) Heatmap view of differential expression gene involved in negative regulation of apoptosis between MSCs and NANP‐treated MSCs. (I) The combination of 25 µM NANP with IT did not enhance anti‐inflammatory cytokine expression compared to IT alone in MSCs ( n = 3). Data were shown as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001; ns, not significant.

    Article Snippet: OT‐I cells were isolated from OT‐I transgenic mouse spleens using the Mouse CD8 + T Cell Isolation Kit (CS103‐01, Vazyme) and labeled with eFluor 670 dye (65‐0840‐85, eBioscience).

    Techniques: Immune Cell, Flow Cytometry, Immunofluorescence, Imaging, RNA Sequencing, Analysis, Gene Expression, Quantitative Proteomics, Migration, Expressing, RNA Expression

    BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

    Article Snippet: To assess autophagic flux, BMDMs transfected with siNC or siTREM2 were co‐cultured with CD8 + T cells for 48 h. Bafilomycin A1 (BafA1, 100 nM, HY‐100558, MCE, USA) was added during the final 4 h of co‐culture.

    Techniques: Western Blot, Expressing, Flow Cytometry, Cell Culture, Membrane, Fluorescence, Co-culture Assay, Transfection, Knockdown, Two Tailed Test

    Single‐cell transcriptomic profiling of the cellular landscape in endometriosis. (A) Schematic representation of the experimental strategy. (B) UMAP visualization of 83,572 cells from 11 samples. (C) UMAP plots split by PF (top) and tissue (bottom) groups. (D) Dot plot showing canonical marker genes used to annotate each cell type. Dot size reflects the fraction of expressing cells, and color depth reflects mean expression. (E) Cell‐type composition of PF samples across individuals. (F) Flow cytometric validation of macrophage proportions in PF (left; Endo, n = 18; Ctrl, n = 10) and CD8 + T cell (middle) and NK cell (right) proportions in tissues (Endo, n = 25; Ctrl, n = 14). (G) Alluvial plot of intercellular signaling patterns. Cell types are connected to communication patterns and their corresponding signaling pathways. Ribbon width is proportional to the relative contribution of each cell type to a given pattern. (H) Cell–cell communication network. Node size reflects total interaction count, and edge width reflects the number of ligand–receptor pairs. (I) Chord diagram of pairwise ligand–receptor interactions. Line color denotes the sender cell type, and line width indicates interaction strength. (J) Outgoing versus incoming interaction strength for each cell type. Macrophages ranked highest on both axes. (K) KEGG enrichment of macrophage‐associated genes, ordered by gene count. Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (F): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, ** p < 0.01.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: Single‐cell transcriptomic profiling of the cellular landscape in endometriosis. (A) Schematic representation of the experimental strategy. (B) UMAP visualization of 83,572 cells from 11 samples. (C) UMAP plots split by PF (top) and tissue (bottom) groups. (D) Dot plot showing canonical marker genes used to annotate each cell type. Dot size reflects the fraction of expressing cells, and color depth reflects mean expression. (E) Cell‐type composition of PF samples across individuals. (F) Flow cytometric validation of macrophage proportions in PF (left; Endo, n = 18; Ctrl, n = 10) and CD8 + T cell (middle) and NK cell (right) proportions in tissues (Endo, n = 25; Ctrl, n = 14). (G) Alluvial plot of intercellular signaling patterns. Cell types are connected to communication patterns and their corresponding signaling pathways. Ribbon width is proportional to the relative contribution of each cell type to a given pattern. (H) Cell–cell communication network. Node size reflects total interaction count, and edge width reflects the number of ligand–receptor pairs. (I) Chord diagram of pairwise ligand–receptor interactions. Line color denotes the sender cell type, and line width indicates interaction strength. (J) Outgoing versus incoming interaction strength for each cell type. Macrophages ranked highest on both axes. (K) KEGG enrichment of macrophage‐associated genes, ordered by gene count. Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (F): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, ** p < 0.01.

    Article Snippet: For CD8 + T cell depletion, mice received intraperitoneal injections of 200 μg anti‐mouse CD8 antibody (BE0061, Bio X Cell, USA) every 3 days.

    Techniques: Single Cell, Profiling, Tissue, Marker, Expressing, Biomarker Discovery, Protein-Protein interactions, Two Tailed Test, MANN-WHITNEY

    CD8 + T cells in endometriosis exhibit a functionally exhausted phenotype. (A) UMAP visualization of T cell subclusters across all samples. (B) Dot plot of canonical marker genes used for T cell subset annotation. (C) Feature plots of CD69 expression on the CD8 + T cell UMAP. (D) Violin plot of terminal exhaustion signature scores in PF CD8 + T cells, shown per sample. Endo samples (left) and Ctrl samples (right) are separated by the dashed line. (E) Representative flow cytometry images and quantification of perforin + CD8 + T cell percentage in PF (Endo, n = 27; Ctrl, n = 15). (F) UMAP of re‐clustered CD8 + T cells from tissue samples. (G) RNA velocity streamlines projected onto the tissue CD8 + T cell UMAP, colored by Seurat cluster identity. (H) Violin plots of progenitor exhaustion signature scores in tissue‐derived CD8 + T cells. (I) Quantification of perforin + CD8 + T cell percentage in tissues (Endo, n = 25; Ctrl, n = 14). (J) Representative flow cytometry images and quantification of GZMB + CD8 + T cell percentage in tissues (Endo, n = 25; Ctrl, n = 14). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (E): Unpaired two‐tailed Student's t ‐test; (I, J): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, **** p < 0.0001.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: CD8 + T cells in endometriosis exhibit a functionally exhausted phenotype. (A) UMAP visualization of T cell subclusters across all samples. (B) Dot plot of canonical marker genes used for T cell subset annotation. (C) Feature plots of CD69 expression on the CD8 + T cell UMAP. (D) Violin plot of terminal exhaustion signature scores in PF CD8 + T cells, shown per sample. Endo samples (left) and Ctrl samples (right) are separated by the dashed line. (E) Representative flow cytometry images and quantification of perforin + CD8 + T cell percentage in PF (Endo, n = 27; Ctrl, n = 15). (F) UMAP of re‐clustered CD8 + T cells from tissue samples. (G) RNA velocity streamlines projected onto the tissue CD8 + T cell UMAP, colored by Seurat cluster identity. (H) Violin plots of progenitor exhaustion signature scores in tissue‐derived CD8 + T cells. (I) Quantification of perforin + CD8 + T cell percentage in tissues (Endo, n = 25; Ctrl, n = 14). (J) Representative flow cytometry images and quantification of GZMB + CD8 + T cell percentage in tissues (Endo, n = 25; Ctrl, n = 14). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (E): Unpaired two‐tailed Student's t ‐test; (I, J): Unpaired two‐tailed Mann‐Whitney U test. * p < 0.05, **** p < 0.0001.

    Article Snippet: For CD8 + T cell depletion, mice received intraperitoneal injections of 200 μg anti‐mouse CD8 antibody (BE0061, Bio X Cell, USA) every 3 days.

    Techniques: Marker, Expressing, Flow Cytometry, Tissue, Derivative Assay, Two Tailed Test, MANN-WHITNEY

    TREM2 + macrophages regulate CD8 + T cell function through SPP1‐CD44 mediated communication. (A) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in PF. (B) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in tissues. (C) Representative CFSE image and quantification of proliferation of CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 8 per group). (D) Relative protein expression of PD‐1 in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (E) Relative Pdcd1 mRNA expression in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (F) Dot plot of statistically significant ligand‐ receptor interactions between TREM2 + macrophages and CD8 + T cells or NK cells in tissues. (G) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (I) Heatmaps of BAG signaling pathway activity in cell–cell communication networks from Ctrl PF and Endo PF. (J) Chord diagrams illustrating BAG signaling pathway interactions among immune cell subsets in Ctrl PF and Endo PF. (K) Western blot analysis and quantification of BAG3 expression in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (L) Representative western blots and quantification of autophagy‐related proteins in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (C): Unpaired two‐tailed Mann‐Whitney U test; (D, E, L): Unpaired two‐tailed Student's t ‐test; (G, H, K): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: TREM2 + macrophages regulate CD8 + T cell function through SPP1‐CD44 mediated communication. (A) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in PF. (B) Cell–cell communication network depicting interactions between TREM2 + macrophages and other immune cell subsets in tissues. (C) Representative CFSE image and quantification of proliferation of CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 8 per group). (D) Relative protein expression of PD‐1 in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (E) Relative Pdcd1 mRNA expression in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages ( n = 3 per group). (F) Dot plot of statistically significant ligand‐ receptor interactions between TREM2 + macrophages and CD8 + T cells or NK cells in tissues. (G) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (I) Heatmaps of BAG signaling pathway activity in cell–cell communication networks from Ctrl PF and Endo PF. (J) Chord diagrams illustrating BAG signaling pathway interactions among immune cell subsets in Ctrl PF and Endo PF. (K) Western blot analysis and quantification of BAG3 expression in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages pretreated with SPP1 neutralizing antibody or CD44 blocking antibody ( n = 3 per group). (L) Representative western blots and quantification of autophagy‐related proteins in CD8 + T cells co‐cultured with WT or TREM2‐KO macrophages ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (C): Unpaired two‐tailed Mann‐Whitney U test; (D, E, L): Unpaired two‐tailed Student's t ‐test; (G, H, K): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001.

    Article Snippet: For CD8 + T cell depletion, mice received intraperitoneal injections of 200 μg anti‐mouse CD8 antibody (BE0061, Bio X Cell, USA) every 3 days.

    Techniques: Cell Function Assay, Immune Cell, Cell Culture, Expressing, Co-culture Assay, Flow Cytometry, Blocking Assay, Activity Assay, Western Blot, Analysis, Two Tailed Test, MANN-WHITNEY

    BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: BAG3‐associated autophagy regulation contributes to TREM2 + macrophage‐induced CD8 + T cell dysfunction. (A) Representative Western blot and quantification of LC3BII accumulation following Bafilomycin A1 (BafA1) treatment ( n = 3 per group). (B) Quantification of P62 protein expression by Western blot following BafA1 treatment ( n = 3 per group). (C, D) Representative flow cytometry image and quantification of mitochondrial oxidative stress in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (E) Representative flow cytometry image and quantification of mitochondrial membrane potential based on JC‐1 fluorescence ratio in CD8 + T cells co‐cultured with siNC or siTREM2 BMDMs following BafA1 treatment ( n = 3 per group). (F) Measurement of ATP levels in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (G, H) Representative flow cytometry images and quantification of apoptosis in CD8 + T cells after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (I) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after co‐culture with siNC or siTREM2 BMDMs with or without BafA1 treatment ( n = 3 per group). (J, K) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage co‐cultured with siNC, siTREM2, or siTREM2 + YM‐1 macrophages ( n = 3 per group). (L) Representative western blot and quantification of BAG3 in siNC and siBag3 CD8 + T cells ( n = 3 per group). (M) Relative Bag3 mRNA expression in siNC and siBag3 CD8 + T cells ( n = 3 per group). (N, O) Representative western blot and quantification of LC3BII expression in CD8 + T cells transfected with siNC or siBAG3 and co‐cultured with WT or TREM2 − / − BMDMs ( n = 3 per group). (P) Representative flow cytometry image and quantification of GZMB + CD8 + T cell percentage after BAG3 knockdown ( n = 3 per group). (Q) ATP measurement in CD8 + T cells after BAG3 knockdown ( n = 3 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (A, D, F, H, I, O, P): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (B, E, K, Q): Kruskal‐Wallis test with Dunn's multiple comparisons post‐hoc test. (L, M): Unpaired two‐tailed Student's t ‐test. * p < 0.05, ** p < 0.01, **** p < 0.0001, ns, not significant.

    Article Snippet: For CD8 + T cell depletion, mice received intraperitoneal injections of 200 μg anti‐mouse CD8 antibody (BE0061, Bio X Cell, USA) every 3 days.

    Techniques: Western Blot, Expressing, Flow Cytometry, Cell Culture, Membrane, Fluorescence, Co-culture Assay, Transfection, Knockdown, Two Tailed Test

    TREM2 deficiency enhances CD8 + T and NK cell cytotoxicity and inhibits endometriotic lesion growth. (A) Representative endometriotic lesion images in WT, TREM2‐KO, TREM2‐KO + anti‐CD8, TREM2‐KO + anti‐NK1.1, and TREM2‐KO + anti‐CD8 + anti‐NK1.1 mice. (B) Quantification of lesion weight across the five groups ( n = 5 per group). (C) Representative flow cytometry gating strategy for analyzing functional markers of CD8 + T cells and NK cells in PF and ectopic lesions from WT and TREM2‐KO mice. (D) Quantification of functional markers by flow cytometry in WT and TREM2‐KO mice ( n = 7 per group). (E) Representative endometriotic lesion image and quantification of lesion weight between isotype and anti‐TREM2 group ( n = 6 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (B): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (D, E): Unpaired two‐tailed Student's t ‐test. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns, not significant.

    Journal: Advanced Science

    Article Title: TREM2 + Macrophages Promote Immune Evasion in Endometriosis Through BAG3‐Associated Regulation of CD8 + T Cell Autophagy

    doi: 10.1002/advs.78385

    Figure Lengend Snippet: TREM2 deficiency enhances CD8 + T and NK cell cytotoxicity and inhibits endometriotic lesion growth. (A) Representative endometriotic lesion images in WT, TREM2‐KO, TREM2‐KO + anti‐CD8, TREM2‐KO + anti‐NK1.1, and TREM2‐KO + anti‐CD8 + anti‐NK1.1 mice. (B) Quantification of lesion weight across the five groups ( n = 5 per group). (C) Representative flow cytometry gating strategy for analyzing functional markers of CD8 + T cells and NK cells in PF and ectopic lesions from WT and TREM2‐KO mice. (D) Quantification of functional markers by flow cytometry in WT and TREM2‐KO mice ( n = 7 per group). (E) Representative endometriotic lesion image and quantification of lesion weight between isotype and anti‐TREM2 group ( n = 6 per group). Data are presented as mean ± SEM. The specific statistical tests used for each panel are as follows: (B): One‐way ANOVA with Tukey's multiple comparisons post‐hoc test. (D, E): Unpaired two‐tailed Student's t ‐test. * p < 0.05, *** p < 0.001, **** p < 0.0001, ns, not significant.

    Article Snippet: For CD8 + T cell depletion, mice received intraperitoneal injections of 200 μg anti‐mouse CD8 antibody (BE0061, Bio X Cell, USA) every 3 days.

    Techniques: Flow Cytometry, Functional Assay, Two Tailed Test

    Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, CD8+ and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: Gene set enrichment analysis (GSEA) was conducted on differentially expressed genes determined by pseudobulk on mouse replicates using all cells captured on D1 and D37 in T2 inflammation. (B) Concentration of IFNγ measured in skin lysates during T2 inflammation (n=5 (D1, D37), 4 (D0, D4, D6, D36) mice). (C) Schematic of ear skin explants from T2-experienced (primary MC903) and control (primary vehicle) ears. Mice were euthanized, MC903 was applied ex vivo and allowed to dry before harvesting, splitting and culturing for 20 hours. (D) qPCR analysis of Ifng and ISGs from ear skin explants normalized to control ears (n=5 explants/condition). (E) Flow cytometric analysis of abundance of CD4+, CD8+ and NK1.1+ cells in D36 recovered skin (n=4 (D0), 5 (D36) mice). (F) Epidermal whole mounts of primary D36 and secondary D72 T2-recovered skin. 5 fields of view (FOV) were quantified across 3 mice/timepoint. Dot plot of Ifng expression scaled by z-score in D37 skin. Flow cytometric analysis of IFNγ+ T cells in D37 skin (n=10 mice). (I) Longitudinal ear thickness curve tracking recovery after end of 6-day treatment window (n=5 mice). Additional scRNA-seq timepoints for T2 inflammation are denoted. (J) Abundance curves for Klra7 + CD8 Teff and CD8+ Trm cells across primary T2 inflammation with additional recovery phase timepoints D10-21. (K) Schematic of CD8+ T cell depletion in primary T2 inflammation. CD103+ CD8+ Trm cells were analyzed in D36 recovered skin (n=6 (Iso), 3 (α-CD8) mice). (L) Ear thickness curve in allergic memory recall (n=5 (Ctrl-T2, α-CD8), 4 (Iso) mice) and (M) immune cell representation on D39 after CD8+ T cell depletion in T2 primary challenge (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (N) Schematic of circulating CD8+ T cell depletion before memory recall with ear thickness curve (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (O) Immune cell populations in D37 skin after circulating CD8+ T cell depletion (n=5 (Ctrl-T2), 6 (Iso, α-CD8) mice). (P-Q) Schematic and ear thickness curves of IFNγ neutralization in (P) secondary (n=5 (Ctrl-T2, Iso), 6 (α-IFNγ) mice) and (Q) primary T2 challenge (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Gene Set Enrichment Analysis, Concentration Assay, Control, Ex Vivo, Analysis, Expressing, Immune Cell, Neutralization

    (A) Concentration of IFNα1 and IFNβ in ear skin lysates in T2 memory (n=3 (D0), 4 (D36, D37) mice). (B) Flow cytometry assessment of residency-associated markers CD69 and CD103 on CD8+ T cells in recovered D36 skin (n=5 mice). (C) Ear thickness curves across primary to tertiary MC903 challenge (n=5 mice). (D) Abundance of CD8+ Trm and Ccl1 + CD8+ Trm relative to full tissue ecosystem over T2 memory timepoints. (E) gMFI of IFNγ in D37 skin samples assessed by flow cytometry across 2 different panels to separately capture NK1.1+ and CD4+ T cells (n=6 mice/panel). (F) Representative H&E images from later primary T2 timepoints capturing peak (D10) and late resolution (D21). (G) Extended primary ear thickness curve during primary CD8+ T cell depletion in T2 inflammation (n=5 mice/group) and (H) flow cytometry results on D39 (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (I) Flow cytometric analysis of CD8+ T cells in blood and skin on D36 after circulating CD8+ T cell depletion (n=3 mice). (J) Extended ear thickness curve for primary and memory T2 inflammation under primary IFNγ neutralization (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Concentration of IFNα1 and IFNβ in ear skin lysates in T2 memory (n=3 (D0), 4 (D36, D37) mice). (B) Flow cytometry assessment of residency-associated markers CD69 and CD103 on CD8+ T cells in recovered D36 skin (n=5 mice). (C) Ear thickness curves across primary to tertiary MC903 challenge (n=5 mice). (D) Abundance of CD8+ Trm and Ccl1 + CD8+ Trm relative to full tissue ecosystem over T2 memory timepoints. (E) gMFI of IFNγ in D37 skin samples assessed by flow cytometry across 2 different panels to separately capture NK1.1+ and CD4+ T cells (n=6 mice/panel). (F) Representative H&E images from later primary T2 timepoints capturing peak (D10) and late resolution (D21). (G) Extended primary ear thickness curve during primary CD8+ T cell depletion in T2 inflammation (n=5 mice/group) and (H) flow cytometry results on D39 (n=3 (Ctrl-T2), 6 (Iso), 5 (α-CD8) mice). (I) Flow cytometric analysis of CD8+ T cells in blood and skin on D36 after circulating CD8+ T cell depletion (n=3 mice). (J) Extended ear thickness curve for primary and memory T2 inflammation under primary IFNγ neutralization (n=5 (Ctrl-T2, α-IFNγ), 10 (Iso) mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Concentration Assay, Flow Cytometry, Tissue, Analysis, Neutralization

    (A) Schematic of 5′ scRNA-seq of sorted CD8+ T cells from D36 and D37 skin to capture Trm, Teff and Tmem cells. (B) UMAP embedding of 7,708 CD8+ T cells across 20 mice (n = 10/timepoint) coloured by cell state. (C) Violin plot depicting expression levels of CD8+ T cell lineage markers along with T2 and T1 effector molecules across all CD8+ T cell states. (D) Intracellular staining of IFNγ and IL-13 across CD103+ CD8+ Trm cells on D36, D37, D72 and D73 skin (n=7 (D36), 8 (D37), 3 (D72), 6 (D73) mice) with (E) representative flow plots for D37 and D73. (F) Flow cytometric quantification of TNF-α production across immune cell types on D37 (n=4 mice). (G) Quantification of abundance and gMFI of GZMB expression across lymphoid populations in D37 (n=9 (% GZMB ), 4 (gMFI) mice). (H) UMAP embedding of 67,173 T cells across 95 patients and 5 studies integrated using Harmony where cell subtypes are annotated and cell clusters are coloured. Study information and clustering details are provided in . (I) Mapping of top 100 genes defining murine allergic Ccl1 + CD8+ Trm state as a gene module across human T cell clusters using patient-level pseudobulk GSVA. (J) Dot plot of lineage-defining, T2 and T1 effector molecule expression across Trm cell subsets. (K) Cell cluster abundances were correlated against Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) scores. Significant associations are highlighted. (L) Quantification of CCL1 + CD8+ Trm cells in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=34 (H), 20 (NL), 41 (L)patients).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Schematic of 5′ scRNA-seq of sorted CD8+ T cells from D36 and D37 skin to capture Trm, Teff and Tmem cells. (B) UMAP embedding of 7,708 CD8+ T cells across 20 mice (n = 10/timepoint) coloured by cell state. (C) Violin plot depicting expression levels of CD8+ T cell lineage markers along with T2 and T1 effector molecules across all CD8+ T cell states. (D) Intracellular staining of IFNγ and IL-13 across CD103+ CD8+ Trm cells on D36, D37, D72 and D73 skin (n=7 (D36), 8 (D37), 3 (D72), 6 (D73) mice) with (E) representative flow plots for D37 and D73. (F) Flow cytometric quantification of TNF-α production across immune cell types on D37 (n=4 mice). (G) Quantification of abundance and gMFI of GZMB expression across lymphoid populations in D37 (n=9 (% GZMB ), 4 (gMFI) mice). (H) UMAP embedding of 67,173 T cells across 95 patients and 5 studies integrated using Harmony where cell subtypes are annotated and cell clusters are coloured. Study information and clustering details are provided in . (I) Mapping of top 100 genes defining murine allergic Ccl1 + CD8+ Trm state as a gene module across human T cell clusters using patient-level pseudobulk GSVA. (J) Dot plot of lineage-defining, T2 and T1 effector molecule expression across Trm cell subsets. (K) Cell cluster abundances were correlated against Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD) scores. Significant associations are highlighted. (L) Quantification of CCL1 + CD8+ Trm cells in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=34 (H), 20 (NL), 41 (L)patients).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Expressing, Staining, Immune Cell

    (A) UMAP embedding of 7,708 CD8+ T cells recovered, split by timepoint (n=10 mice/timepoint). (B) Violin plot showing representative markers of CD8+ Trm1, Trm17, Teff and Tmem cell states. (C) Stacked bar plot showing cell state abundances on a per-mouse basis across 10 mice per timepoint. (D) CITE-seq assessment of cell surface CD103, CD69, CD62L and CD44 levels across CD8+ Trm1, Trm17, Tmem and Teff populations. (E) Flow cytometric assessment of TNF-α gMFI on D37 across lymphoid and myeloid lineages in skin (n=4 mice).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) UMAP embedding of 7,708 CD8+ T cells recovered, split by timepoint (n=10 mice/timepoint). (B) Violin plot showing representative markers of CD8+ Trm1, Trm17, Teff and Tmem cell states. (C) Stacked bar plot showing cell state abundances on a per-mouse basis across 10 mice per timepoint. (D) CITE-seq assessment of cell surface CD103, CD69, CD62L and CD44 levels across CD8+ Trm1, Trm17, Tmem and Teff populations. (E) Flow cytometric assessment of TNF-α gMFI on D37 across lymphoid and myeloid lineages in skin (n=4 mice).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques:

    (A) 5 public scRNA-seq datasets of AD skin featuring full thickness and suction blister biopsies (GSE147424, GSE230575, GSE204765, GSE153760, GSE158432) were integrated using Harmony and re-annotated to produce a final dataset of 568,080 cells across 95 patients. Additional details in Methods. (B) UMAP embedding of 568,080 cells showing annotated cell types from one round of clustering defined using markers specified in Methods. (C) T cells ( CD3E + CD3D +) were subclustered and cluster-defining marker expression is displayed. Related UMAP is shown in  . (D) Stacked bar chart showing cell patient biopsy. (E) Quantification of additional cell clusters in addition to  for their abundances in each biopsy across healthy (H), non-lesional (w)oannganesionliavel l (NL) and lesional (L) ski (H),Shift(NL), 41 (L) patients).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) 5 public scRNA-seq datasets of AD skin featuring full thickness and suction blister biopsies (GSE147424, GSE230575, GSE204765, GSE153760, GSE158432) were integrated using Harmony and re-annotated to produce a final dataset of 568,080 cells across 95 patients. Additional details in Methods. (B) UMAP embedding of 568,080 cells showing annotated cell types from one round of clustering defined using markers specified in Methods. (C) T cells ( CD3E + CD3D +) were subclustered and cluster-defining marker expression is displayed. Related UMAP is shown in . (D) Stacked bar chart showing cell patient biopsy. (E) Quantification of additional cell clusters in addition to for their abundances in each biopsy across healthy (H), non-lesional (w)oannganesionliavel l (NL) and lesional (L) ski (H),Shift(NL), 41 (L) patients).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Marker, Expressing

    (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Abundance plots for co-occurring CD8+ T cell and Tnc -Hi iFB states nominated by proportionality network in Fig 2J. (B) Violin plot showing expression of T1 and T2 cytokine receptors along with selected differentially expressed markers of iFB states. (C) Flow cytometry was used to determine IL-15Rα positivity across CD31+ endothelial, CD45+ immune, PDGFRα+ fibroblasts and Ep-CAM+ epithelial cells (n=4 mice). Schematic and D37 ear thickness of IL-15 blockade prior to T2 memory (n=8 mice/group). Abundance of CD8+ T cells in D37 skin measured by flow cytometry (n=5 (Iso), 4 (α-IL-15) mice). (F) gMFI of IL-15-mediated support markers GZMB , IFNγ and Ki-67 in CD103+ and CD103-CD8+ T cells on D37 (n=3 (Iso), 4 (α-IL-15) mice). (G) Schematic of primary ear skin fibroblast isolation for cytokine stimulation. Heatmap of Il15ra and Il15 expression scaled as z-score across cytokine stimulation conditions (n=4 (IFNγ/TNF-α), 8 (single cytokine) mice). (H) Representative pSTAT1 staining in D37 skin from PDGFRα-eGFP mice. Yellow arrowheads denote pSTAT1+ PDGFRα+ fibroblasts. Schematic of intradermal AAV administration for STAT1 signaling modulation prior to T2 recall with associated ear thicknesses on D37 (n=7 (GFP, STAT1ca), 6 (STAT1dn) mice). FLAG-STAT1ca+ PDGFRa+ fibroblasts were compared with FLAG-untransduced fibroblasts for IL-15Rα gMFI on D37 (n=4 mice). (K) Frequency of GZMB positivity (n=11(GFP), 8 (STAT1ca) mice) and (L) GZMB gMFI were measured in CD103+ Trm cells and CD103-recruited cells on D37 in AAV-injected mice (n=15 (GFP), 12 (STAT1ca) mice). (M) UMAP embedding of 97,393 fibroblasts across 70 patients and 5 studies where subtypes are annotated (reticular rFB, papillary pFB, immune-interacting iiFB, nerve-associated nFB and hair follicle-associated hFB) and clusters are coloured. Study information is provided in and cluster definitions in . (N) Mapping of the top 50 genes defining murine Tnc -Hi iFB subtype as a gene module across human fibroblast clusters using patient-level pseudobulk GSVA. (O) Cell cluster abundances were correlated against vIGA-AD scores. Significant associations are highlighted. (P) Quantification of IL4I1 + pFB abundance in biopsies across healthy (H), non-lesional (NL) and lesional (L) skin (n=19 (H), 20 (NL), 31 (L) patients). (Q) Violin plot of genes stimulated by T2 and T1 effector cytokines across severity-associated human fibroblast clusters.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Expressing, Flow Cytometry, Isolation, Staining, Injection

    (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) Stacked bar plot showing representation of 15 scRNA-seq fibroblast clusters across T2 inflammation timepoints. (B-D) Flow cytometric evaluation of (B) CD103+ CD8+ Trm counts (n=8 (Iso), 9 (α-IL15) mice), (C) CD8+ T cell proportions (n=5 (Iso), 4 (α-IL15) mice), and (D) frequency of GZMB + CD8+ Trm (n=3 (Iso), 4 (α-IL15) mice) in skin at D37 after IL-15 neutralization before T2 memory recall. (E) Schematic of intradermal AAV injection with CAG-mCherry genome and flow cytometric assessment of PDGFRα+ and CD31+ cell tropism in skin after 3 days (n=4 mice). (F) Schematic for generating and stimulating 3T3 stable cell lines with doxycycline-inducible GFP, STAT1ca and STAT1dn plasmids in piggyBac vectors. Heatmap showing significant 24-hour transcriptional changes assessed by bulk RNA-seq (n=3 biological replicates/condition). (G) PCA of stably transfected 3T3 cell lines stimulated with IFNγ for 0 or 24 hours with or without 4-hour prior doxycycline induction for expression of STAT1 variant.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Neutralization, Injection, Stable Transfection, RNA Sequencing, Transfection, Expressing, Variant Assay

    (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: (A) CellChat cell-cell communication analysis of chemokine pathways between structural cells and CD8+ T cell states nominated by proportionality analysis in . (B) Dot plot of Cxcl12 and Ccl19 expression scaled by z-score in T2 single-cell timecourse. (C) CXCL12 and CCL19 protein levels in ear skin lysates across primary and secondary MC903. (D) Dot plot of single-cell fibroblast CCL19 expression across healthy (H), AD non-lesional (NL) and AD lesional (L) human skin. (E) Proportion of CXCR4+ cells across immune cell subtypes present in skin on D13 of T2 inflammation (n=18 mice). (F) Ear thickness curve of primary MC903 with treatment by EPI-X4 to block CXCR4-mediated recruitment (n=25 mice/condition). EPI-X4 or ethanol vehicle-control treatment days are denoted by arrows. (G) Immune cell representation in D13 skin after EPI-X4 treatment (n=6 mice/condition). (H) Explant schematic and Ccl19 qPCR after 20-hour culture (n=5 explants). (I) Schematic of Transwell CD8+ T cell migration assays to explant-conditioned media with antibody-mediated CCL19 blockade. Migrated CD8+ T cells in the lower chamber were counted by flow cytometry (n=3 explants/condition). (J) Heatmap of Ccl19 expression by primary fibroblasts after Trm-derived cytokine stimulation measured by bulk RNA-seq (n=8 mice/condition). (K) Schematic of TNF-α blockade prior to T2 recall with ELISA measurement of CCL19 levels on D37 in ear skin lysates (n=8 (Iso), 9 (α-TNF-α) mice). (L) One-day ear thickness changes with TNF-α blockade (n=8 mice/condition). (M) Quantification of abundance of NK1.1+ cells and T cells in D37 skin after TNF-α blockade (n=8 mice/condition). (N) Concentration of IL-4 in skin lysates in T2 memory (n=4 mice/timepoint). (O) Left: Schematic illustrating hypothesized interaction between IL-4 and TNF-α signaling in iFBs. Right: qPCR analysis of primary dermal fibroblasts stimulated with IL-4, TNF-α or the combination for 48 hours (n=3 mice/condition).

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Analysis, Expressing, Single Cell, Immune Cell, Blocking Assay, Control, Migration, Flow Cytometry, Derivative Assay, RNA Sequencing, Enzyme-linked Immunosorbent Assay, Concentration Assay, Significance Assay, Gene Expression

    Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Journal: bioRxiv

    Article Title: A fibroblast-CD8+ T cell circuit drives a Type 1 shift in allergic inflammatory memory

    doi: 10.64898/2026.11.02.763646

    Figure Lengend Snippet: Primary allergic inflammation induced by MC903 initiates a TSLP-driven keratinocyte response that promotes a T2 environment driven by IL-4 and IL-13 secretion from Th2 cells and basophils. Upon recovery, epidermal-resident allergic CD8+ Trm cells, a reservoir of inflammatory memory, are established in murine skin. Upon T2 recall, a mixed inflammatory environment is established with rapid recruitment of T1 and T2 effectors. Re-activated allergic CD8+ Trm cells producing IFNγ, TNF-α and IL-13 drive this T2-to-T1 shift in memory and form a two-cell circuit with dermal fibroblasts. Responding to CD8+ Trm-derived T1 effector cytokines, fibroblasts trans-present IL-15 to enhance the effector profile of CD8+ T cells, and recruit circulating T cells via CCL19 secretion. Concurrent IL-4 signaling potentiates both amplification arms of the fibroblast–CD8+ T cell circuit.

    Article Snippet: CD8+ T cells were then purified by negative selection using the Mouse CD8+ T Cell Isolation Kit (Miltenyi 130-104-075).

    Techniques: Derivative Assay, Amplification

    (A) Murine constructs binding PD-1 only (Mu-mono-PD-1) or AXL and PD-1 (Mu-BiTE-AXL/PD-1). (B) Binding of mono-AXL and Mu-BiTEto 4NQO-T sgCT (control) and sgAXL cells by flow cytometry. Log scale (FL1), MFI at right; representative of two biological experiments; mean ± SEM of biological duplicates (n=2). Statistical significance was determined using one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (C) Binding of Mu-mono-PD-1 and Mu-BiTE to wild-type (WT) splenocytes, unstimulated versus Concanavalin A (ConA, 1 µg/mL)-stimulated by flow cytometry. Log scale (FL1), MFI at right; single experiment. (D) Schematic of antigen-specific cytotoxicity assay. (E,F) Killing of gp100-pulsed 4NQO-T (n=5) (E) and mEERL (n=4) (F) (target, T), by gp100-reactive CD8+ T cells; antibodies at 5 µg/mL, 1:4 T:E ratio; caspase-3/7 by flow cytometry at 16h. Mean ± SEM. Statistical significance was determined using a one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (G) Tumor volume in 4NQO-T CDX subcutaneous model. Randomized mice received i.p. injections twice weekly: Mu-BiTE at various concentrations (0.1, 1, 5 mg/kg) or vehicle (PBS). (n = 6-10 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test compared to vehicle only (only significant P values shown). (H, I) Tumor volume in 4NQO-T CDX (H) and mEERL CDX (I) orthotopic lip models. Randomized mice received i.p. injections twice weekly: mono-Abs combination (mono-AXL+Mu-mono-PD-1, 5 mg/kg each), Mu-BiTE (7.6 mg/kg molar equivalent or 5 mg/kg), or vehicle (PBS). (n = 5-7 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test (adjusted P values shown).

    Journal: bioRxiv

    Article Title: Spatially enforced engagement of PD-1⁺ T cells with AXL⁺ cells reprograms the tumor microenvironment and overcomes anti-PD-1 resistance

    doi: 10.64898/2026.10.26.761755

    Figure Lengend Snippet: (A) Murine constructs binding PD-1 only (Mu-mono-PD-1) or AXL and PD-1 (Mu-BiTE-AXL/PD-1). (B) Binding of mono-AXL and Mu-BiTEto 4NQO-T sgCT (control) and sgAXL cells by flow cytometry. Log scale (FL1), MFI at right; representative of two biological experiments; mean ± SEM of biological duplicates (n=2). Statistical significance was determined using one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (C) Binding of Mu-mono-PD-1 and Mu-BiTE to wild-type (WT) splenocytes, unstimulated versus Concanavalin A (ConA, 1 µg/mL)-stimulated by flow cytometry. Log scale (FL1), MFI at right; single experiment. (D) Schematic of antigen-specific cytotoxicity assay. (E,F) Killing of gp100-pulsed 4NQO-T (n=5) (E) and mEERL (n=4) (F) (target, T), by gp100-reactive CD8+ T cells; antibodies at 5 µg/mL, 1:4 T:E ratio; caspase-3/7 by flow cytometry at 16h. Mean ± SEM. Statistical significance was determined using a one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown). (G) Tumor volume in 4NQO-T CDX subcutaneous model. Randomized mice received i.p. injections twice weekly: Mu-BiTE at various concentrations (0.1, 1, 5 mg/kg) or vehicle (PBS). (n = 6-10 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test compared to vehicle only (only significant P values shown). (H, I) Tumor volume in 4NQO-T CDX (H) and mEERL CDX (I) orthotopic lip models. Randomized mice received i.p. injections twice weekly: mono-Abs combination (mono-AXL+Mu-mono-PD-1, 5 mg/kg each), Mu-BiTE (7.6 mg/kg molar equivalent or 5 mg/kg), or vehicle (PBS). (n = 5-7 per group). Average tumor volume ± SEM. Statistical significance was determined using a permutation test (adjusted P values shown).

    Article Snippet: Following blocking, the sections were incubated overnight at 4 °C with the primary antibody CD8 (CST-85336S, 1:200) and CD45 (CST-13917S, 1:200) diluted in blocking solution.

    Techniques: Construct, Binding Assay, Control, Flow Cytometry, Two Tailed Test, Cytotoxicity Assay

    (A ) Conceptual workflow for multiplex spatial data analysis. (B) Representative multiplex images showing nuclei (DAPI, blue), cancer-associated fibroblasts (CAFs; αSMA⁺, red), CD8⁺ T cells (CD8, green), and dendritic cells (CD11c, magenta), together with cell type–colored segmentation masks illustrating treatment-dependent remodeling of the tumor microenvironment. Scale bars, 100 µm. (C) Cell-type composition (%) of major cell populations across treatment groups. (D-K) Fractional abundance of selected cell populations across treatment groups. (D) Epithelial (tumor) cells; (E) Proliferating epithelial cells (fraction of epithelial cells); (F) DCs; (G) B lymphocytes; (H) NK cells; (I) CD4⁺ T cells; (J) CD8⁺ T cells; (K) activated CD8⁺ T cells (fraction of CD8⁺ T cells). Median and IQR with Tukey whiskers; points represent individual biological replicates (n=3). Statistical significance was determined using binomial generalized linear models with a logit link. (L) Composition of the T-cell compartment across treatment groups, showing the relative proportions of CD4⁺ T cells, CD8⁺ T cells, Tregs, and T lymphocytes (unsorted). (M-T) Zone-specific distribution of selected cell populations across treatment groups, weighted by the overall abundance of each cell type within the corresponding group. (M) Epithelial (tumor) cells; (N) Proliferating epithelial cells; (O) DCs; (P) B lymphocytes; (Q) NK cells; (R) CD4⁺ T cells; (S) CD8⁺ T cells; (T) Activated CD8⁺ T cells. Lines represent the mean and shaded bands represent the SEM of biological triplicates (n=3).

    Journal: bioRxiv

    Article Title: Spatially enforced engagement of PD-1⁺ T cells with AXL⁺ cells reprograms the tumor microenvironment and overcomes anti-PD-1 resistance

    doi: 10.64898/2026.10.26.761755

    Figure Lengend Snippet: (A ) Conceptual workflow for multiplex spatial data analysis. (B) Representative multiplex images showing nuclei (DAPI, blue), cancer-associated fibroblasts (CAFs; αSMA⁺, red), CD8⁺ T cells (CD8, green), and dendritic cells (CD11c, magenta), together with cell type–colored segmentation masks illustrating treatment-dependent remodeling of the tumor microenvironment. Scale bars, 100 µm. (C) Cell-type composition (%) of major cell populations across treatment groups. (D-K) Fractional abundance of selected cell populations across treatment groups. (D) Epithelial (tumor) cells; (E) Proliferating epithelial cells (fraction of epithelial cells); (F) DCs; (G) B lymphocytes; (H) NK cells; (I) CD4⁺ T cells; (J) CD8⁺ T cells; (K) activated CD8⁺ T cells (fraction of CD8⁺ T cells). Median and IQR with Tukey whiskers; points represent individual biological replicates (n=3). Statistical significance was determined using binomial generalized linear models with a logit link. (L) Composition of the T-cell compartment across treatment groups, showing the relative proportions of CD4⁺ T cells, CD8⁺ T cells, Tregs, and T lymphocytes (unsorted). (M-T) Zone-specific distribution of selected cell populations across treatment groups, weighted by the overall abundance of each cell type within the corresponding group. (M) Epithelial (tumor) cells; (N) Proliferating epithelial cells; (O) DCs; (P) B lymphocytes; (Q) NK cells; (R) CD4⁺ T cells; (S) CD8⁺ T cells; (T) Activated CD8⁺ T cells. Lines represent the mean and shaded bands represent the SEM of biological triplicates (n=3).

    Article Snippet: Following blocking, the sections were incubated overnight at 4 °C with the primary antibody CD8 (CST-85336S, 1:200) and CD45 (CST-13917S, 1:200) diluted in blocking solution.

    Techniques: Multiplex Assay, Analysis

    (A) Representative spatial maps of cellular communities in vehicle, combination, and BiTE-treated tumors. Each cell is colored according to its community assignment, highlighting treatment-dependent changes in spatial organization, clustering, and infiltration patterns. (B) Normalized cellular composition of identified communities. Bars represent the mean fractional contribution of major cell types within each community. (C-H) Fractional abundance of selected communities across treatment groups. (C) proliferating tumor (pTumor); (D) pTumor-CAF-DC; (E) Tumor-CAF; (F) Tumor-DC-CD8; (G) CD8-DC; (H) Tumor-DC. Median and IQR with Tukey whiskers; points represent individual biological replicates (n=3). Statistical significance was determined using binomial generalized linear models with a logit link. (I) Relative community enrichment of Mu-BiTE and Combination tumors across communities. Bars indicate the proportion of cells contributed by each treatment group within a given community; values sum to 100% for each community. (J,K) Heatmaps showing the proportion of CD8⁺ T-cell functional states across communities and treatments. (J) Activated CD8⁺ T cells (Granzyme B⁺) and (K) exhausted CD8⁺ T cells, both as a percentage of total CD8⁺ T cells within each community. (L) Heatmap showing the ratio of activated to exhausted CD8⁺ T cells across communities and treatments. (M-R) Zone-specific distribution of selected communities across treatments, weighted by overall abundance within the corresponding treatment group. (M) pTumor; (N) pTumor-CAF-DC; (O) Tumor-CAF; (P) Tumor-DC-CD8; (Q) CD8-DC; (R) Tumor-DC. Lines represent the mean and shaded bands represent the SEM of biological triplicates (n=3). (S) Flow cytometry quantification of CD8⁺ T cell proliferation following co-culture with gp100-pulsed conventional DCs (cDCs, top) or monocyte-derived DCs (MoDCs, bottom) ± PBS / combination / BiTE treatments. Mean ± SEM of biological triplicates (n=3). Statistical significance was determined using a one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown).

    Journal: bioRxiv

    Article Title: Spatially enforced engagement of PD-1⁺ T cells with AXL⁺ cells reprograms the tumor microenvironment and overcomes anti-PD-1 resistance

    doi: 10.64898/2026.10.26.761755

    Figure Lengend Snippet: (A) Representative spatial maps of cellular communities in vehicle, combination, and BiTE-treated tumors. Each cell is colored according to its community assignment, highlighting treatment-dependent changes in spatial organization, clustering, and infiltration patterns. (B) Normalized cellular composition of identified communities. Bars represent the mean fractional contribution of major cell types within each community. (C-H) Fractional abundance of selected communities across treatment groups. (C) proliferating tumor (pTumor); (D) pTumor-CAF-DC; (E) Tumor-CAF; (F) Tumor-DC-CD8; (G) CD8-DC; (H) Tumor-DC. Median and IQR with Tukey whiskers; points represent individual biological replicates (n=3). Statistical significance was determined using binomial generalized linear models with a logit link. (I) Relative community enrichment of Mu-BiTE and Combination tumors across communities. Bars indicate the proportion of cells contributed by each treatment group within a given community; values sum to 100% for each community. (J,K) Heatmaps showing the proportion of CD8⁺ T-cell functional states across communities and treatments. (J) Activated CD8⁺ T cells (Granzyme B⁺) and (K) exhausted CD8⁺ T cells, both as a percentage of total CD8⁺ T cells within each community. (L) Heatmap showing the ratio of activated to exhausted CD8⁺ T cells across communities and treatments. (M-R) Zone-specific distribution of selected communities across treatments, weighted by overall abundance within the corresponding treatment group. (M) pTumor; (N) pTumor-CAF-DC; (O) Tumor-CAF; (P) Tumor-DC-CD8; (Q) CD8-DC; (R) Tumor-DC. Lines represent the mean and shaded bands represent the SEM of biological triplicates (n=3). (S) Flow cytometry quantification of CD8⁺ T cell proliferation following co-culture with gp100-pulsed conventional DCs (cDCs, top) or monocyte-derived DCs (MoDCs, bottom) ± PBS / combination / BiTE treatments. Mean ± SEM of biological triplicates (n=3). Statistical significance was determined using a one-way ANOVA followed by two-tailed Tukey’s multiple comparisons test with correction for multiple comparisons (adjusted P values shown).

    Article Snippet: Following blocking, the sections were incubated overnight at 4 °C with the primary antibody CD8 (CST-85336S, 1:200) and CD45 (CST-13917S, 1:200) diluted in blocking solution.

    Techniques: Functional Assay, Flow Cytometry, Co-culture Assay, Derivative Assay, Two Tailed Test